Phathom Pharmaceuticals (PHAT) PEG Ratio
Market Cap: $289.00M
Avg Volume: 1.22M
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Phathom Pharmaceuticals's trailing twelve month (TTM) PEG ratio is -0.15.
- Phathom Pharmaceuticals's annual PEG ratio as of today is -0.04.
- Phathom Pharmaceuticals's quarterly PEG ratio is 0.09.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Phathom Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -1.53
- Quarterly: -1.94
- TTM: -0.88
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 9.28
- Quarterly: 19.45
- TTM: 5.23
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: -2.02
- Quarterly: -2.27
- TTM: -1.16
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -1.92
- Quarterly: -9.09
- TTM: -1.11
These metrics provide insights into Phathom Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-0.15
Annual PEG Ratio
-0.04
Quarterly PEG Ratio
0.09
Phathom Pharmaceuticals Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Phathom Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | -0.04 | -1.53 | 9.28 | -2.02 | -1.92 |
| 2023 | 0.07 | -2.32 | 686.61 | -6.44 | -3.40 |
| 2022 | -0.05 | -1.97 | 0.00 | -5.87 | -3.00 |
| 2021 | 19.71 | -4.91 | 0.00 | 10.09 | -4.90 |
| 2020 | 0.16 | -8.28 | 0.00 | 5.68 | -15.84 |
| 2019 | 0.00 | -3.67 | 0.00 | 3.38 | -21.09 |
| 2018 | 0.00 | -163.84 | 0.00 | -164.09 | -206.28 |
Related Metrics
Explore detailed financial metrics and analysis for PHAT.